Background Cardiovascular disease (CVD) is a common comorbidity in type 2 diabetes
(T2DM). CVD's prevalence has been growing over time. Purpose To estimate the current …

Introduction Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in
people with type 2 diabetes mellitus (T2DM). The objectives of this systematic literature …

The prevalence of type 2 diabetes mellitus (DM2) increases markedly with age. Antidiabetic
treatment and the objectives of glycaemic control in elderly patients with DM2 should be …

La prevalencia de la diabetes mellitus tipo 2 (DM2) se incrementa marcadamente con la
edad. El tratamiento antidiabético y los objetivos de control glucémico en el anciano con …

Background Chronic kidney disease (CKD) is increasingly recognized as a global health
issue and it affects 10% to 15% of the world population. Diabetes mellitus is the leading …

Aims To assess the prevalence of stage 3–5 chronic kidney disease (CKD) at baseline and
to identify associated risk factors. To determine the effect of CKD and CKD stage according …

Background: Recent data suggest that the higher risk of end-stage renal disease in women
compared with men is associated with waist circumference. We investigated whether …

Background The purpose of this study was to analyze the evolution of vascular, cardiac and
renal target organ damage (TOD) in patients with increased insulin resistance over a 3.5 …

Objective The present study investigates the impact of quality of care (QoC) and other factors
on chronic kidney disease (CKD) stage progression among Type 2 Diabetes Mellitus …

Metabolic syndrome (MS) is a cluster of risk factors which associated with cardiovascular
disease, myocardial infraction, stroke, and mortality due to these diseases. There is not a …